نتائج البحث - Michael Sticherling

تنقيح النتائج
  1. 1
    COVID-19: risk for cytokine targeting in chronic inflammatory diseases?

    COVID-19: risk for cytokine targeting in chronic inflammatory diseases? حسب Georg Schett, Michael Sticherling, Markus F. Neurath

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Localization of Neutrophil-Activating Peptide-1/Interleukin-8-Immunoreactivity in Normal and Psoriatic Skin

    Localization of Neutrophil-Activating Peptide-1/Interleukin-8-Immunoreactivity in Normal and Psoriatic Skin حسب Michael Sticherling, Erika Bornscheuer, Jens‐M. Schröder, Enno Christophers

    منشور في 1991
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Paradoxical reactions to biologicals in chronic inflammatory systemic diseases

    Paradoxical reactions to biologicals in chronic inflammatory systemic diseases حسب Igor Kremenevski, Oliver Sander, Michael Sticherling, Martin Raithel, firstname lastname

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts.

    IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. حسب J.‐M. Schröder, Michael Sticherling, H H Henneicke, W. C. Preissner, Enno Christophers

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

    IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. حسب Dirk Schadendorf, A. Möller, Bernd Algermissen, Margitta Worm, Michael Sticherling, B. M. Czarnetzki

    منشور في 1993
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The CXC Receptor 2 Is Overexpressed in Psoriatic Epidermis

    The CXC Receptor 2 Is Overexpressed in Psoriatic Epidermis حسب Reinhard Kulke, Erika Bornscheuer, C Schlüter, Joachim Bartels, Joachim Röwert, Michael Sticherling, Enno Christophers

    منشور في 1998
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria

    Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria حسب Barbara Hermes, Ann-Karin Prochazka, Norbert Haas, K Jurgovsky, Michael Sticherling, Beate M. Henz

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Human Thy-1 (CD90) on Activated Endothelial Cells Is a Counterreceptor for the Leukocyte Integrin Mac-1 (CD11b/CD18)

    Human Thy-1 (CD90) on Activated Endothelial Cells Is a Counterreceptor for the Leukocyte Integrin Mac-1 (CD11b/CD18) حسب Anne Wetzel, Triantafyllos Chavakis, Klaus T. Preissner, Michael Sticherling, Uwe‐Frithjof Haustein, Ulf Anderegg, Anja Saalbach

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

    COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses حسب Filippo Fagni, David Simón, Koray Taşçılar, Verena Schoenau, Michael Sticherling, Markus F. Neurath, Georg Schett

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum.

    Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. حسب I Sylvester, Teizo Yoshimura, Michael Sticherling, Jens‐Michael Schröder, M. Ceska, P. Peichl, Edward J. Leonard

    منشور في 1992
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus

    Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus حسب Michael Sticherling, Matthias Augustin, Wolf‐­Henning Boehncke, Enno Christophers, Silja Domm, Harald Gollnick, Kristian Reich, Ulrich Mrowietz

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial

    Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized contr... حسب Michael Sticherling, Ulrich Mrowietz, Matthias Augustin, Diamant Thaçi, Nima Melzer, Christian Hentschke, J Kneidl, Christian Sieder, Kristian Reich

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Mutations in IL36RN in Patients with Generalized Pustular Psoriasis

    Mutations in IL36RN in Patients with Generalized Pustular Psoriasis حسب Andreas Körber, Rotraut Mößner, Regina Renner, Heinrich Sticht, Dagmar Wilsmann‐Theis, Peter Schulz, Michael Sticherling, Heiko Traupe, Ulrike Hüffmeier

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial

    Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERS... حسب Sascha Gerdes, Beate Bräu, Matthias Hoffmann, Bernhard Korge, Dariusch Mortazawi, Franca Wiemers, Sven Wegner, Yvonne Personke, Mario Gomez, Michael Sticherling

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis

    Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis حسب David Simón, Francesca Faustini, Arnd Kleyer, Judith Haschka, Matthias Englbrecht, Sebastian Kraus, Axel J. Hueber, Roland Kocijan, Michael Sticherling, Georg Schett, Jürgen Rech

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

    Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study حسب Eleni Kampylafka, David Simón, Isabelle d’Oliveira, Christina Linz, Veronika Lerchen, Matthias Englbrecht, Jürgen Rech, Arnd Kleyer, Michael Sticherling, Georg Schett, Axel J. Hueber

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    DeepNAPSI multi-reader nail psoriasis prediction using deep learning

    DeepNAPSI multi-reader nail psoriasis prediction using deep learning حسب Lukas Folle, Pauline Fenzl, Filippo Fagni, Mareike Thies, Vincent Christlein, Christine Meder, David Simón, Ioanna Minopoulou, Michael Sticherling, Georg Schett, Andreas Maier, Arnd Kleyer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Simultaneous quantification of bone erosions and enthesiophytes in the joints of patients with psoriasis or psoriatic arthritis - effects of age and disease duration

    Simultaneous quantification of bone erosions and enthesiophytes in the joints of patients with psoriasis or psoriatic arthritis - effects of age and disease duration حسب David Simón, Arnd Kleyer, Francesca Faustini, Matthias Englbrecht, Judith Haschka, Andreas Berlin, Sebastian Kraus, Axel J. Hueber, Roland Kocijan, Michael Sticherling, Jürgen Rech, Georg Schett

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients

    Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients حسب Roland Kocijan, Matthias Englbrecht, Judith Haschka, David Simón, Arnd Kleyer, Stephanie Finzel, Sebastian Kraus, Heinrich Resch, Christian Muschitz, Klaus Engelke, Michael Sticherling, Jürgen Rech, Georg Schett

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

    Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSA... حسب Eleni Kampylafka, Isabelle d’Oliveira, Christina Linz, Veronika Lerchen, Fabian Stemmler, David Simón, Matthias Englbrecht, Michael Sticherling, Jürgen Rech, Arnd Kleyer, Georg Schett, Axel J. Hueber

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: